Advanced Enzyme Technologies Limited (ADVENZYMES.NS)
INR 375.8
(1.24%)
INR 375.8
(1.24%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.51 Billion | 1.4 Billion | 1.22 Billion | 1.62 Billion | 1.4 Billion | 1.28 Billion |
| Net Income | 1.33 Billion | 1.4 Billion | 1.71 Billion | 2.1 Billion | 1.79 Billion | 1.61 Billion |
| Depreciation & Amortization | 352.42 Million | 350.29 Million | 349.83 Million | 284.12 Million | 257.78 Million | 211.16 Million |
| Deferred income taxes | - | - | - | -578.76 Million | -515.47 Million | -473.38 Million |
| Stock-based compensation | 30.31 Million | - | - | 3.81 Million | 8.88 Million | 14.13 Million |
| Change in working capital | -262.52 Million | -3.41 Million | -273.99 Million | -150.28 Million | -155.96 Million | -121.02 Million |
| Other non-cash items | 1.06 Billion | -347.14 Million | -563.51 Million | -33.68 Million | 22.22 Million | 35.14 Million |
| Investing Cash Flow | -831.95 Million | -2.98 Billion | -249.12 Million | -260.33 Million | -444.98 Million | -1.24 Billion |
| Investments in PPE | -473.13 Million | -381.81 Million | -281.76 Million | -195.8 Million | -506.51 Million | -123.86 Million |
| Acquisitions | 1.55 Million | -65.45 Million | -218.6 Million | -16.26 Million | 2.04 Million | -17.47 Million |
| Investment purchases | -360.37 Million | -2.68 Billion | -213.64 Million | -58.88 Million | -10.24 Million | -1.11 Billion |
| Sales/Maturities of investments | - | 65.45 Million | 220.99 Million | 75.13 Million | -2.04 Million | -1.14 Million |
| Other Investing Activities | -223.36 Million | 81.74 Million | 243.89 Million | -64.52 Million | 71.77 Million | 6.2 Million |
| Financing Cash Flow | -507.06 Million | -257.98 Million | -273.75 Million | -263.1 Million | -385.54 Million | -430.86 Million |
| Debt repayment | -120.55 Million | -3.22 Million | -88.12 Million | -236.89 Million | -112.97 Million | -312.89 Million |
| Dividends payments | -567.12 Million | -125.42 Million | -118.6 Million | -79.81 Million | -105.24 Million | -80.45 Million |
| Common Stock Repurchased | - | -62.76 Million | 313.03 Million | 247.44 Million | 150.16 Million | 312.89 Million |
| Common Stock Issuance | - | 1.42 Million | 4.34 Million | 3 Million | 1.77 Million | 1.14 Million |
| Other Financing Activities | -56.07 Million | -68 Million | -384.4 Million | -196.84 Million | -319.26 Million | -351.55 Million |
| Accounts receivables | 9.26 Million | -99.54 Million | -14.04 Million | -72.24 Million | -139.05 Million | -85.16 Million |
| Accounts payables | -39.41 Million | 60.28 Million | 27.98 Million | 14.73 Million | -6.79 Million | -77.25 Million |
| Inventory | -238.34 Million | 7.55 Million | -260.95 Million | -81.8 Million | -5.2 Million | -2.22 Million |
| Other working capital | 5.96 Million | 28.3 Million | -26.98 Million | -10.97 Million | -4.92 Million | 43.61 Million |
| Cash at beginning of period | 970.12 Million | 2.67 Billion | 1.91 Billion | 826.64 Million | 230.62 Million | 611.28 Million |
| Cash at end of period | 1.43 Billion | 964.2 Million | 2.67 Billion | 1.91 Billion | 826.64 Million | 230.62 Million |
| Capital Expenditure | -473.13 Million | -381.81 Million | -281.76 Million | -195.8 Million | -506.51 Million | -123.86 Million |
| Effect of forex changes on cash | -1.51 Million | 126.62 Million | 54.32 Million | -18.96 Million | 17.54 Million | 11.08 Million |
| Net cash flow / Change in cash | 464.85 Million | -1.7 Billion | 754.36 Million | 1.09 Billion | 596.02 Million | -380.66 Million |
| Free Cash Flow | 1.04 Billion | 1.02 Billion | 941.15 Million | 1.43 Billion | 902.49 Million | 1.16 Billion |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 283.11 Million | 1.33 Billion | 417.74 Million | 344.08 Million | 288.1 Million | 1.4 Billion |
| Depreciation & Amortization | - | 352.42 Million | 86.04 Million | 87.27 Million | 86.34 Million | 350.29 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 30.31 Million | 30.31 Million | - | - | - | - |
| Change in working capital | - | -262.52 Million | - | - | - | -3.41 Million |
| Other non-cash items | -313.42 Million | 1.06 Billion | -417.74 Million | -344.08 Million | -288.1 Million | -347.14 Million |
| Investing Cash Flow | - | -831.95 Million | - | - | - | -2.98 Billion |
| Investments in PPE | - | -473.13 Million | - | - | - | -381.81 Million |
| Acquisitions | - | 1.55 Million | - | - | - | -65.45 Million |
| Investment purchases | - | -360.37 Million | - | - | - | -2.68 Billion |
| Sales/Maturities of investments | - | - | - | - | - | 65.45 Million |
| Other Investing Activities | - | -223.36 Million | - | - | - | 81.74 Million |
| Financing Cash Flow | - | -507.06 Million | - | - | - | -257.98 Million |
| Debt repayment | - | -120.55 Million | - | - | - | -3.22 Million |
| Dividends payments | - | -567.12 Million | - | - | - | -125.42 Million |
| Common Stock Repurchased | - | - | - | - | - | -62.76 Million |
| Common Stock Issuance | - | - | - | - | - | 1.42 Million |
| Other Financing Activities | - | -56.07 Million | - | - | - | -68 Million |
| Accounts receivables | - | 9.26 Million | - | - | - | -99.54 Million |
| Accounts payables | - | -39.41 Million | - | - | - | 60.28 Million |
| Inventory | - | -238.34 Million | - | - | - | 7.55 Million |
| Other working capital | - | 5.96 Million | - | - | - | 28.3 Million |
| Cash at beginning of period | - | 970.12 Million | 1.26 Billion | 1.08 Billion | 970.12 Million | 2.67 Billion |
| Cash at end of period | - | 1.43 Billion | 1.43 Billion | 1.26 Billion | 1.14 Billion | 964.2 Million |
| Capital Expenditure | - | -473.13 Million | - | - | - | -381.81 Million |
| Effect of forex changes on cash | - | -1.51 Million | - | - | - | 126.62 Million |
| Net cash flow / Change in cash | - | 464.85 Million | 172.08 Million | 174.54 Million | 172.68 Million | -1.7 Billion |
| Free Cash Flow | - | 1.04 Billion | 172.08 Million | 174.54 Million | 172.68 Million | 1.02 Billion |
0QYE
KOKUYOCMLN
6451
AHLUCONT
2360
SRTS